What do I need to know about immunoglobulin light chain (AL) amyloidosis?

Research output: Contribution to journalArticle

92 Scopus citations

Abstract

Immunoglobulin light chain (AL) amyloidosis is the most common acquired systemic amyloidoses. Its presentation is often insidious and progressive, which may delay diagnosis. The interval between first symptoms and actual diagnosis along the intrinsic heterogeneity of tissue tropism create a wide spectrum of presentations, both in terms of scope and depth of symptoms and signs and functional status of patients. In this review, the authors review the pathogenesis, diagnosis and differential diagnosis of AL amyloidosis along with the prognosis and state-of-the-art management for patients with this affliction.

Original languageEnglish (US)
Pages (from-to)137-154
Number of pages18
JournalBlood Reviews
Volume26
Issue number4
DOIs
StatePublished - Jul 1 2012

Keywords

  • Amyloidosis
  • Monoclonal gammopathy
  • Multisystem disease
  • Prognosis
  • Transplantation

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'What do I need to know about immunoglobulin light chain (AL) amyloidosis?'. Together they form a unique fingerprint.

  • Cite this